All News

Hospitals have endorsed the movement toward Regional Care Organizations (RCOs), which would guide the transition away from fee-for-service. But a looming budget gap is an immediate concern, while Alabama's Medicaid costs keep climbing.

In addition to recommendations on alternate techniques, the revised guideline, being jointly developed by CAP, IASLC, and AMP, will also include testing for emerging biomarkers in lung cancer.

After their decision to include Abbvie's triple combination for hepatitis C on their formulary, over Gilead's more expensive regimens, Express Scripts indicated at the J. P. Morgan Healthcare Conference that they'll continue the stance of choosing treatments that are equally effective but save costs, especially in cancer.

The retrospective analysis of 145 patients with stage 2-3 rectal cancer found that the "wait and watch" approach, instead of surgery, in patients treated with chemotherapy might work just as well when measuring survival as an outcome.

Older adults with diabetes are being overtreated for their condition, leading to harmful outcomes such as hypoglycemia, according to a study published in JAMA Internal Medicine.

The increasing popularity of retail clinics to provide basic care is bring driven by many factors, including consumer interest in transparency, cost, and convenience. Malls are beneficiaries of the shift.

Merck and Eli Lilly have entered an agreement to collaborate on clinical trials to evaluate the former's recently approved PD-1 inhibitor, Keytruda (pembrolizumab) in combination with Lilly's oncology agents in several clinical trials targeting multiple tumor types.

The US Supreme Court on Monday declined to take up another broad challenge to President Barack Obama's signature healthcare law, this time from the Association of American Physicians and Surgeons and the Alliance for Natural Health USA.

Not only do a majority of older patients expect e-prescriptions, but 81% preferred e-prescriptions to paper in a study published in the Perspectives in Health Information Management.

The study evaluated data collected through a global collaboration between research institutes in the United States, India, and Africa. Study results pointed to a high rate of exposure of non-smoking teenagers to second-hand smoke, both at home and outside.

The number of cancer survivors may be on the rise, but they experience continuing issues that can impair their quality of life beyond 5 years of survival, according to a new study published in Cancer.

Advocacy groups have gone to federal court to force states to make higher payments to Medicaid providers to improve access. But a spokesman for state Medicaid officials said the courts are an inappropriate place for such disputes.

23andMe is betting its growing troves of genetic data will prove essential to drug companies, medical researchers, and even health and wellness companies.

Providers and patient advocates nationwide are deeply worried about a US Supreme Court case that they say could restrict their ability across the country to seek judicial relief from low Medicaid reimbursement rates.

The pre-clinical study by researchers at the Wellcome Trust Sanger Institute in UK point to the gene BCL11A as a possible driver of this aggressive form of breast cancer.

A new study reports on the first year of the implementation of OPTIMISTIC, an innovative program they developed and implemented to prevent unnecessary hospitalizations of nursing facility residents.

Mid-trial evaluation by an independent Data Monitoring Committee found overall survival with Opdivo (nivolumab) in the Checkmate-017 trial was significantly better than the control arm. BMS now plans to submit results to the FDA for approval of the PD-1 inhibitor in lung cancer.

Interferon-free combination therapy in hepatitis C patients who undergo liver transplantation can eliminate the virus, according to 2 studies published in Gastroenterology.

New telehealth bill signed into law in New York will bring much-needed healthcare to rural and underserved communities and require Medicaid to reimburse telehealth service costs.

The combination of 2 Medi-Cal primary care rate decreases could mean primary care providers who see a lot of Medi-Cal patients will have to scale back or stop seeing those beneficiaries.

Studies from RAND and the Urban Institute estimate that eliminating subsidies for the federally facilitated Marketplaces would increase premiums between 35% and 47% and cause at least 8.2 million people to drop coverage.

Health insurer Anthem Inc has reached a deal under which Gilead Sciences Inc's hepatitis C drug Harvoni will be the primary treatment for patients infected with the most common strain of the liver-destroying virus.

As retailers struggle to keep up with changing shopping trends, mall operators across the US are looking to fill spaces left empty by the likes of Sears and RadioShack. There is one promising new group of tenants: walk-in medical clinics.

Cost cutting and new initiatives aimed at bringing in more patients will lead to another strong year in 2015 for for-profit hospitals. Meanwhile, their not-for-profit counterparts have been given negative outlooks by credit-rating agencies.

In comments to the House Committee on Energy and Commerce, Health Subcommittee, ASCO strongly supported the FDA's resolution to rigorously regulate laboratory-developed tests.

The study, published in the journal Cancer Prevention Research found that HPV persisted for 12 months or more in men older than 45 years of age, which could increase their susceptibility to developing head and neck cancer.

While nanotechnology has led to countless advancements, a group of Israeli researchers are now raising a flag of caution about its effects on our health. They say exposure to tiny silica-based particles can play a big role in increasing heart attack and stroke risks.

In command and ready for a fight, Republicans ignored a White House veto threat and advanced a bill in Congress that would curb President Barack Obama's healthcare overhaul by redefining full-time work as 40 hours a week.

The Consumer Financial Protection Bureau and the Kaiser Family Foundation have both examined how rising cost-sharing and the complexity of medical billing put patients at a disadvantage when they are most vulnerable. Patients tell the CFPB that bill collectors are calling even when they can't get complete information about the medical bill in question.

The FDA approved on Thursday a new anti-clotting drug to reduce the risk of stroke and dangerous blood clot in patients with non-valvular atrial fibrillation.